Evolution of IgM, IgE and IgG1-4 antibody responses in early childhood monitored with recombinant allergen components: Implications for class switch mechanisms

European Journal of Immunology

Volumn 32, Issue 2, 2002, Pages 576-584

  Niederberger, Verena ^a   Niggemann, Bodo ^b   Kraft, Dietrich ^c   Spitzauer, Susanne ^c   Valenta, Rudolf ^c,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

IgE; Isotype switch; Recombinant pollen allergen; Type I allergy

Indexed keywords

ALLERGEN; CYTOKINE; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BIRCH; CELL CULTURE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; GENE REARRANGEMENT; GRASS POLLEN; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN GENE; IMMUNOPATHOGENESIS; INFANT; MALE; PERINATAL PERIOD; POLLEN ALLERGY; PRIORITY JOURNAL; SENSITIZATION; SEROLOGY;

AGE FACTORS; ALLERGENS; ANIMALS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MODELS, IMMUNOLOGICAL; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 0036182689     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200202)32:2<576::AID-IMMU576>3.0.CO;2-U     Document Type: Article

References (43)

1. Allergy and allergic disease
2. Biology and genetics of atopic disease
3. Signalling through the high-affinity IgE receptor FcεRI
4. Recombinant allergen molecules: Tools to study effector cell activation
5. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE
6. IgE-mediated allergen presentation via FcεRI on antigen-presenting cells
7. FcεRI-expressing antigen-presenting cells: New players in the atopic game
8. Consequences of IgE/CD23-mediated antigen presentation in allergy
9. Upregulation of FcεRI on human basophils by IgE antibody is mediated by interaction of IgE with FcεRI
10. Regulation of the IgE isotype switch: New insights on cytokine signals and the functions of ε germline transcripts
11. Regulation of isotype switching
12. To E or not to E? Can an IL-4-induced B cell choose between IgE and IgG4?
13. The murine IgG1/IgE class switch program
14. IL-4 induction of IgE class switching by lipopolysaccharide-activated murine B cells occurs predominantly through sequential switching
15. Frequency of immunoglobulin E class switching is autonomously determined and independent of prior switching to other classes
16. lg μ-ε isotype switch in IL-4-treated human B lymphoblastoid cells. Evidence for a sequential switch
17. Evidence for a human lgG1 class switch program
18. Switch circles from IL-4-directed ε class switching from human B lymphocytes
19. Multiple types of chimeric germ-line lg heavy chain transcripts in human B cells: Evidence for trans-splicing of human lg RNA
20. Direct and sequential switching from μ to ε in patients with Schistosoma mansoni infection and atopic dermatitis
21. In vivo and in vitro IgE isotype switching in human B lymphocytes: Evidence for a predominantly direct IgM to IgE class switch program
22. Antibody repertoire development in fetal and neonatal piglets. I. Four VH genes account for 80% of VH usage during 84 days of fetal life
23. Antibody repertoire development in fetal and neonatal piglets. II. Characterization of heavy chain complementarity-determining region 3 diversity in the developing fetus
24. Antibody repertoire development in fetal and newborn piglets. III. Colonization of the gastrointestinal tract selectively diversifies the pre-immune repertoire in mucosal lymphoid tissues
25. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5)
26. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE
27. The gene coding for the major birch pollen allergen Bet v 1, is highly homologous to a pea disease resistance response gene
28. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: A quantitative IgE inhibition study with sera from different populations
29. Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy
30. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT)
31. Maximal rise in IgE antibody following ragweed pollination season
32. IgA production without μ or δ chain expression in developing B cells
33. Local synsthesis of ε germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure
34. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching
35. In vitro production of IgE by human peripheral blood mononuclear cells. III. Demonstration of a circulating IgE-bearing cell involved in the spontaneous IgE biosynthesis
36. Immunological changes associated with allergen immunotherapy
37. Allergen-specific IgE production of committed B cells from allergic patients in vitro
38. Effects of IL-4 and IL-13 on total and allergen-specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens
39. Atopic diseases in infancy. The German Multicenter Atopy Study (MAS-90)
40. Natural course of sensitization to food and inhalant allergens during the first 6 years of life
41. High-level expression and purification of the major birch pollen allergen, Bet v 1
42. Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen
43. Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen, Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction